Certara, Inc. Common Stock CERT
Analyst Ratings
- Consensus
- Moderate Buy — 4 Buy · 6 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $9.70 (-8.7% downside)
Key Stats
- Today's Range
- $10.42 – $10.86
- 50-Day Range
- $7.58 – $12.61
- 52-Week Range
- $4.45 – $12.94
- Volume
- 205K shs
- Average Volume
- 2.47 million shs
- Market Cap
- $1.63 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.72%
- Days to Cover
- 1.00
About Certara, Inc. Common Stock
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Related Stocks
Compare head-to-head: CERT vs MSFT·CERT vs PLTR·CERT vs ORCL·CERT vs CRM
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
